Buy this book
- About this book
-
In recent years, cannabis research has concentrated on the potential of cannabinoids as therapeutic substances, particularly in serious chronic illnesses such as multiple sclerosis. Most volumes published on cannabinoids so far concentrate on the biological activity, biochemistry and pharmacology, whereas this volume concentrates on the diseases, the physiological effects and therapeutic use of cannabinoids. The volume editor Prof. Mechoulam was the first who isolated the prime active constituent (THC, Tetrahydrocannabiol) of marijuana. He published extensively on the pharmacological activities of cannabinoids. The volume is of interest to researchers and clinicians from pharmacology, neuroscience, and medicinal research.
- Table of contents (14 chapters)
-
-
Cannabis in India: ancient lore and modern medicine
Pages 1-22
-
Cannabinoid chemistry: an overview
Pages 23-46
-
Cannabidiol as a potential medicine
Pages 47-65
-
Endocannabinoids and regulation of fertility
Pages 67-78
-
Cannabinoids in neurodegeneration and neuroprotection
Pages 79-109
-
Table of contents (14 chapters)
Recommended for you
Bibliographic Information
- Bibliographic Information
-
- Book Title
- Cannabinoids as Therapeutics
- Editors
-
- Raphael Mechoulam
- Series Title
- Milestones in Drug Therapy
- Copyright
- 2005
- Publisher
- Birkhäuser Basel
- Copyright Holder
- Birkhäuser Basel
- eBook ISBN
- 978-3-7643-7358-0
- DOI
- 10.1007/3-7643-7358-X
- Hardcover ISBN
- 978-3-7643-7055-8
- Series ISSN
- 2296-6056
- Edition Number
- 1
- Number of Pages
- X, 268
- Topics
*immediately available upon purchase as print book shipments may be delayed due to the COVID-19 crisis. ebook access is temporary and does not include ownership of the ebook. Only valid for books with an ebook version. Springer Reference Works are not included.
